Skip to content
Home/Companies/Biotech/Exonate
Exonate

Exonate

Biotech·UK·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns Exonate?

Exonate is a British Biotech company, currently owned by ACF Investors since 2016.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ACF Investors
Investor
ACF Investors
Angel CoFund · 2011 · VC

Key facts

HQUK
SectorBiotech
Websitewww.exonate.com

More from Angel CoFund

Other portfolio companies in the same fund.

Atelerix
Atelerix
Active
BiotechUK· 2025
FLIT
Active
TMTUK· 2025
Hammer Missions
Hammer Missions
Active
SoftwareUK· 2025
Monument Therapeutics
Active
BiotechUK· 2025
Teal Connect Ltd
Active
TelecomUK· 2025
Arrow Risk Management
Arrow Risk Management
Active
FinancialsUK· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Exonate?

Exonate is currently owned by ACF Investors, through Angel CoFund, since 2016.

When did ACF Investors acquire Exonate?

ACF Investors acquired Exonate in 2016.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue